Cardiovascular considerations for patients with COVID-19 and candidate drugs against SARS-CoV-2
Cited by 0
Related Papers
USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart
|Circulation|2023|114
Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future
|Cell Biology and Toxicology|2024|65
Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia–reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination
|Acta Pharmaceutica Sinica B|2022|56
The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling
|Journal of Molecular and Cellular Cardiology|2019|44
Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling
|Frontiers in Pharmacology|2017|38